STATBOLIC 2026 Advances Statistical Science in Cardiometabolic Drug Development April 1, 2026 Leave a Comment The conference—dedicated to advancing statistical innovation in cardiometabolic drug development—brought together industry, academic, and regulatory statisticians committed to advancing treatments for metabolic disorders.